Thetechnology is a method of blockading CTPS1 as a target for therapeutics intreating neointima-related disorders. Specifically, the invention aims to be vascularsmooth muscle specific anti-proliferative drugs for the next-generation drugeluting stents. Vascular remodeling as a result of smooth musc.....
[更多]
This technology follows a process that enables the production of flexible and transparent substrates such as mono-crystalline silicon that can be used as a platform for semiconductor printing and wiring in electronic devices. The process is cost-effective and can be made compatible with the conven.....
[更多]
Where current adjuvants act by one or several of the following mechanisms, the Th17-class of adjuvants mediate all of the following: Increase antigen transport and uptake (phagocytosis) by antigen-presenting cells Provide a long-lasting depot effect, i.e., antigenic reservoir .....
[更多]
Dr. John Katzenellenbogen from the University of Illinois has designed Pathway preferential estrogens (PaPEs) that are novel synthetic compounds that structurally resemble the natural estrogen but with its reduced binding affinity, form ER-PaPE complex with a short lifetime of seconds.
[更多]
· Sensitive: This method offers a 16-fold enhancement in detection efficiency compared to standard fluorescent immunoassays. · Simple and inexpensive: The scaffold is constructed from common materials (silica, polymer shrink films), and reagents are added by simple sol-gel methods. · Rapid: Like oth.....
[更多]
| |< <- | [6531] [6532] [6533] [6534] [6535] [6536] [6537] [6538] [6539] [6540] [6541] | -> >| |
